Bernstein SocGen Group reiterated an Outperform rating and $313.00 price target on Humana ... with the stock currently appearing undervalued based on comprehensive Fair Value analysis.

Humana’s stock continues to attract mixed opinions ... Our Pro platform offers fair value estimates, performance predictions, and risk assessments, along with additional tips and expert analysis.

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers ...

Bernstein SocGen Group reiterated an Outperform rating and $313.00 price target on Humana (NYSE ... range from $244 to $402, with the stock currently appearing undervalued based on comprehensive Fair ...

Home Depot's SRS Distribution deal boosts pro market reach, but weak growth, high valuation, and cyclical risks suggest ...

Healthcare conglomerate CVS Health CVS formed its Health Services segment through a realignment tied to a new operating model ...

Hyster-Yale faces challenges with three declining quarters after prior growth. Read here for an analysis of HY stock and why ...

To achieve its goal, Humana told investors it's set several targets, including increasing preventative care visits by 20% this year.

This was the stock's fourth consecutive day of gains.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The stock's fall snapped a five-day winning streak.